The relation between treatment benefit and underlying risk in meta-analysis.
about
Thrombolysis for acute ischaemic strokePosture and fluids for preventing post-dural puncture headacheThrombolysis for acute ischaemic strokeRelation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapyIndividual patient data meta-analysis : Cervical stitch (cerclage) for preventing pregnancy loss in womenSingle- versus two- layer intestinal anastomosis: a meta-analysis of randomized controlled trials.Statistical strategies for avoiding false discoveries in metabolomics and related experimentsIssues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomesStatins for primary prevention: at what coronary risk is safety assured?Bench-to-bedside review: avoiding pitfalls in critical care meta-analysis--funnel plots, risk estimates, types of heterogeneity, baseline risk and the ecologic fallacyThe evidence base for diabetes technology: appropriate and inappropriate meta-analysisCompliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study.'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data.Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysisSystematic reviews and meta-analysis: a structured review of the methodological literature.Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleadingManufacturers affect clinical results of THA with zirconia heads: a systematic review.Modelling the effect of baseline risk in meta-analysis: a review from the perspective of errors-in-variables regression.Applying the results of clinical trials to patients to general practice: perceived problems, strengths, assumptions, and challenges for the future.A meta-regression analysis of treatment effect modifiers in trials with flexible-dose oral sildenafil for erectile dysfunction in broad-spectrum populations.Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis.A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.Meta-analysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux.Meta-analysis and investigation of anti-infective therapies.Commentary: On Effect Measures, Heterogeneity, and the Laws of Nature.Revisiting the relation between change and initial value: a review and evaluation.Recent developments in meta-analysis.Exploring heterogeneity in meta-analyses: needs, resources and challenges.Factors explaining the heterogeneity of effects of patient decision aids on knowledge of outcome probabilities: a systematic review sub-analysis.Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials.Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all.Zinc supplementation for the prevention of acute lower respiratory infection in children in developing countries: meta-analysis and meta-regression of randomized trials.Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response.Systematic reviews and meta-analyses of randomized trials: principles and pitfalls.Effect model law: an approach for the implementation of personalized medicine.Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.Measuring the individual benefit of a medical or behavioral treatment using generalized linear mixed-effects models.Methods for exploring heterogeneity in meta-analysis.Standardization of terminology in meta-analysis: a proposal for working definitions.
P2860
Q24194788-147DFF1B-1901-4EA7-9A5A-72DC1627E875Q24201239-E3EA3A85-A5C6-4180-985B-647091150347Q24240067-EBB613CF-A86F-4D41-B66E-EC85F399944CQ24594496-6D55D140-6D1D-4FE6-A831-602D15804731Q24799361-AD312111-A94F-409F-8F4C-8E6299FE2272Q25257134-4911A856-D835-426F-BA56-0F111E7FEC50Q27887473-63B3F515-3B02-4ACB-94F7-7BA91824E3CCQ28193390-708D0968-1D79-459F-9165-F9B92C847651Q28362569-A0C3C58D-3EA4-4186-B759-126E21F20F87Q28756698-386635F8-5708-4079-873A-019EE84C882CQ30409804-54CDCEFB-1B66-49B6-92C0-B41CB2A40CB3Q30476674-DB06250A-0E82-4EED-8A86-5CFDC54F87D1Q33261643-AD66E14F-BC2D-4C42-87F0-E6B904EA9FB4Q33497692-F4DFD323-B872-47C4-BD34-AD5A91544D2FQ33645850-7B065094-D308-4397-B8A6-D845FB9ACAB0Q33651245-5468C9E0-8FC1-4761-9EBC-4EB24D86E6B2Q33838709-25661466-0790-484B-9243-0DE7719FC7D8Q34015951-1178341B-FBE2-46C7-A407-63C7E9F7AE8CQ34469512-715A46F6-EC1C-415E-A7F4-1501BE4B8581Q34524277-5BBFB427-7086-4559-AAAE-639FD40301EFQ35639202-B551798A-2401-419D-BF75-67888285DEAAQ35745058-D27012B4-37C6-475C-8E5F-63AF004230EDQ36096071-57708EBE-6B8F-4907-83D8-98D03EA49340Q36179740-2B0C7751-A564-4E37-956E-451C03A0179BQ36206113-B044F74D-35DA-4A7C-9E41-F8EC316BB615Q36417014-75D3E545-AC6E-4439-9D2D-D8DDDDB4C367Q36859537-276C7865-687A-4F98-A448-2D2B56289033Q37072917-54C00AFA-C337-4EAB-A295-1CED9E23F3FDQ37368791-C45AC090-6504-46B2-9F4B-033B461A98A1Q37624213-E35CF843-9597-428D-9C60-EFB637C834F6Q37640968-0E220E08-9595-4EF6-9EA8-C005EBC7AF48Q37692741-BEDE0519-D785-4F50-B541-93D9D9662757Q37769977-3CA55708-A94A-4E61-BBBA-4806151758CDQ38257403-690B4F71-3540-4A62-AD3E-E4340E4398F8Q38270447-1205D8DE-4B4C-407D-83C7-A28C0E493D6EQ38308754-8D69E227-995B-4FAA-81A1-E69F7D872FF1Q38939820-60DEA536-BA20-45B3-B945-7F1FE4A5837FQ39669644-8B1ADA2F-F346-4100-9AD6-89BC92303999Q40689559-F7C0465F-2763-4882-8631-EA2A8B6A7E0DQ41691009-F3958118-1126-4D10-BCB4-25325DFC376C
P2860
The relation between treatment benefit and underlying risk in meta-analysis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
The relation between treatment benefit and underlying risk in meta-analysis.
@en
The relation between treatment benefit and underlying risk in meta-analysis.
@nl
type
label
The relation between treatment benefit and underlying risk in meta-analysis.
@en
The relation between treatment benefit and underlying risk in meta-analysis.
@nl
prefLabel
The relation between treatment benefit and underlying risk in meta-analysis.
@en
The relation between treatment benefit and underlying risk in meta-analysis.
@nl
P2093
P2860
P356
P1433
P1476
The relation between treatment benefit and underlying risk in meta-analysis.
@en
P2093
P2860
P304
P356
10.1136/BMJ.313.7059.735
P407
P577
1996-09-01T00:00:00Z